AsortinoBeta
Penumbra Inc. logo

PENPenumbra Inc.

NYSEStockHealthcareMedical Devices🇺🇸 United StatesISIN US70975L1070penumbrainc.com
$322.17+0.32%
NYSE · at close Sep 4, 2026
Tokenized by
Backed Finance logoReality logo
2 issuersOn
Solana logoXLayer logoTON logoEthereum logo
11 chains

Chart data are delayed by 15 minutes.

1D+0.32%
1M0.63%
3M+0.48%
1Y+15.18%
3Y+21.98%
5Y+16.10%

Main metrics

$12.69B
$57.53<0.01% of mkt cap
79.35
$4.06
281.4K
0.70
$221.2652-week range$362.41

About PEN

Penumbra Inc. is a medical device company that designs, develops, manufactures, and markets products for interventional therapies in vascular and neurological care. Its portfolio centers on thrombectomy systems used to remove blood clots, including solutions for peripheral and neurovascular applications, along with access devices, embolization technologies, and neurosurgical tools. The company’s products are used in acute care settings by hospitals and physicians to support treatment of conditions such as stroke, pulmonary embolism, deep vein thrombosis, aneurysms, and other vascular disorders. Penumbra Inc. serves healthcare providers in the United States and international markets, positioning itself as a specialist in minimally invasive devices for complex clot-removal and vascular intervention procedures. Founded in 2004 and headquartered in Alameda, California, Penumbra Inc. focuses on medical technologies that address critical and time-sensitive clinical needs.

Similar products

Abbott Laboratories logo
ABTNYSE
$108.330.42%
Abbott Laboratories
Ondo Finance logoBacked Finance logoReality logo
4 issuers · 15 chains
Bruker Corp. logo
BRKRNASDAQ
$58.501.53%
Bruker Corp.
Reality logo
1 issuer · 2 chains
Boston Scientific Corp. logo
BSXNYSE
$47.80+1.81%
Boston Scientific Corp.
Backed Finance logoReality logoDinari Inc. logo
3 issuers · 14 chains
DexCom Inc. logo
DXCMNASDAQ
$87.902.02%
DexCom Inc.
Backed Finance logoReality logoDinari Inc. logo
3 issuers · 13 chains